4HRA: Crystal Structure Of Dot1l In Complex With Epz-5676 reference: Potent inhibition of DOT1L as treatment for MLL-fusion leukemia., Daigle SR, Olhava EJ, Therkelsen CA, Basavapathruni A, Jin L, Boriack-Sjodin PA, Allain CJ, Klaus CR, Raimondi A, Scott MP, Waters NJ, Chesworth R, Moyer MP, Copeland RA, Richon VM, Pollock RM, Blood. 2013 Jun 25. PMID: 23801631 |
This OCA
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).